Stay updated with breaking news from பொறியியலாளர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Photo Credit: IANS IANSLive New Delhi, June 9 (IANS) The initial public offering of automobile technology company Sona BLW Precision Forgings shares will open on June 14.
Top Story May 6, 2021 ISLAMABAD: Chairman Pakistan People’s Party Bilawal Bhutto Zardari has said the PTI regime is busy enriching Prime Minister Imran Khan s cronies in cartels and mafias through engineered inflation. Bilawal said the sharp rise in tomato prices by up to 67 percent and the prime minister s complete apathy to the plight of the people is a proof that Imran Khan is the ringleader of this inflation mafia and his friends are minting money by raising prices. “Living for low-income families has become unbearable and that it was injustice to allow landlords to increase rents at a time when so many of our fellow countrymen were dealing with inflation and unemployment,” he said in a statement on Wednesday. ....
Medical Engineered Materials Market worth $29.1 billion by 2025 - Exclusive Report by MarketsandMarkets Medical Engineered Materials Market by Type (Medical plastics, medical foams, medical films, medical elastomers, medical adhesives), Application (Medical device, disposables, medical wearables, advanced wound care), and Region - Global Forecast to 2025 , published by MarketsandMarkets, the global Medical Engineered Materials Market size is projected to reach USD 29.1 billion by 2025 from USD 15.8 billion in 2020, at a CAGR of 13.0% during the forecast period. Increase in aging population, rise in global healthcare expenditure, growing demand for minimally invasive medical procedures, and advancements in designing of medical electronics are the major drivers for the medical engineered materials market. ....
Mar 17 2021 Read 132 Times Human antibodies developers IONTAS and FairJourney Biologics have entered into an agreement with Quell Therapeutics regarding IONTAS / FJB’s proprietary libraries and technology platforms. Quell is harnessing the suppressive capacity of Tregs to develop engineered Treg cell therapies to address several conditions of immune dysfunction. Under the terms of the agreement, IONTAS / FJB will provide Quell with a diverse panel of novel target binders, ranging in affinities, to enable Quell to select functional binders for chimeric antigen receptor (CAR) development against undisclosed targets. The collaboration is non-exclusive and further terms of the agreement are not being disclosed. ....
PESHAWAR/SUKKUR/LAHORE: Terming resignations from parliament as necessary for the success of the long march, the Pakistan Democratic Movement head Maulana Fazlur Rehman said here Monday that the. ....